HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

urokinase inhibitor

from leucocytes; can be inactivated by cathepsin D
Networked: 20 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Stürzebecher, Jörg: 2 articles (03/2010 - 04/2005)
2. Beloglazova, I B: 1 article (03/2015)
3. Tkachuk, V A: 1 article (03/2015)
4. Sulimov, V B: 1 article (03/2015)
5. Plekhanova, O S: 1 article (03/2015)
6. Stambol'skii, D V: 1 article (03/2015)
7. Katkova, E V: 1 article (03/2015)
8. Rysenkova, K D: 1 article (03/2015)
9. Boeck, S: 1 article (03/2013)
10. Bevan, P: 1 article (03/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Pancreatic Neoplasms (Pancreatic Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Breast Neoplasms (Breast Cancer)
5. Atherosclerosis

Related Drugs and Biologics

1. gemcitabine
2. Urokinase-Type Plasminogen Activator (Urokinase)
3. Plasminogen Activators (Plasminogen Activator)
4. 4- iodine- benzo(b)thiophene- 2- carboxamidine (B 428)
5. 4-aminobenzamidine
6. Serine Proteases (Serine Protease)
7. Estrogen Receptor Modulators (Antiestrogen)
8. Succinic Acid (Succinate)
9. Uric Acid (Urate)
10. Tamoxifen